Replies to post #435539 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

In April 2021, LP stated getting TLD/Publication done is their first, second and third top priority. The “process” referred to below, is finalized by TLD and Journal publication.

"So first of all is the process for Phase III trial results. We know everyone is very anxious to see the results of the trial. As I think everybody knows, back on October 5th [2020] we outlined the process that we would be going through to get to the stage where the results can be announced. And I want to assure everyone that the Phase III trial and the analysis of the data are the most important topic that everyone in this company is focusing on. It has the full focus and attention of our management and our Board as well. Every resource we have has been and is being brought to bear on it. As we say, ‘it is our number one, number two, and number three priority.’ There’s nothing more important to the company. I’d like to be able to go into the details that we know everybody is craving, and understandably so, but we are in a quiet period now, while the data are being reviewed and analyzed. We’ve explained the process that we’re going through, it’s six stages of various analyses and reviews by various parties. And I can assure everyone that we are committed to completing this full process that we outlined at the outset, back when we did data lock.